NIOX NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies | ||
Founding Date | Founding Date 1948 | Founding Date 2006 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Morrisville, US HQ Bad Homburg Vor Der Höhe, DE Uppsala, SE Morrisville, US | |
Employees | Employees 650 | Employees 91 |
Financial | ||
Revenue (est.) | Revenue (est.) £731.3m (FY, 2019) | Revenue (est.) £48.7m (FY, 2025) |
Cost of goods | Cost of goods £221m (FY, 2019) | Cost of goods £11.1m (FY, 2025) |
Gross profit | Gross profit £510.3m (FY, 2019) | Gross profit £38.2m (FY, 2025) |
Net income | Net income £88.3m (FY, 2019) | Net income £7m (FY, 2025) |
NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies
View company